Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study.
Article
Sharafeldin, Noha, Wang, Xuexia, Wang, Fan et al. (2023). Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study.
. JOURNAL OF CLINICAL ONCOLOGY, (16_suppl), 12090.
Sharafeldin, Noha, Wang, Xuexia, Wang, Fan et al. (2023). Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study.
. JOURNAL OF CLINICAL ONCOLOGY, (16_suppl), 12090.